About Galileo Life Sciences
Top-tier life sciences advisory through a lean model.
Galileo Life Sciences (GLS) was founded in 2022 by Charles-André Brouwers (CAB), drawing on 30 years of experience at the Boston Consulting Group and Capgemini. Inspired by a desire to offer high-quality, senior-led consulting, CAB launched GLS with the support of close partners as a purpose-built boutique for the life sciences industry.
GLS is designed to deliver high-impact results through focused, efficient engagements. Its lean structure, agile operating model, and hands-on senior involvement enable the firm to tailor its support precisely to each client’s needs—without the overhead of larger consulting firms.
Additionally, GLS maintains a close affiliation with Galileo Global Securities (GGS), a private market investment bank. This relationship allows GLS to offer a unique combination of strategic consulting and transaction support to growth-stage life sciences companies seeking financing or partnerships.